Functionally, LUCAT1 directly targeted HIF1α, facilitating tumor growth, which could be reversed by CRISPR–Cas9-mediated depletion of LUCAT1 (Huang H. et al., 2024). This evidence concerns the gene LUCAT1 and neoplasm.